Riskpilot← Back to searchSign inGet full accessSYMRA LEGESENTER AS
ASActiveOrg 825269312Cecilie Thoresens Vei 17, 1153 OsloGeneral medical practice activities · NACE 8621Est. 20206 employees
Revenue 2024
NOK 6,9M
+17% vs 2023
EBITDA margin
6.7%
+400% vs 2023
Equity ratio
6.0%
Financial strength
Net profit 2024
NOK 245K
+167% vs 2023
| Revenue | NOK 6,9M | +17% |
| EBITDA | NOK 458K | +400% |
| Net profit | NOK 245K | +167% |
| Total assets | NOK 1,9M | -1% |
| Equity | NOK 116K | +190% |
| Employees | 6 | — |
Legal name
SYMRA LEGESENTER AS
Org number
825269312
Legal form
Aksjeselskap
NACE code
8621 · General medical practice activities
Founded
29. juni 2020
Share capital
NOK 30 000
Employees
6 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Company purpose
Drive kontorfellesskap for samarbeidende leger ved symra legesenter as.
Address
Cecilie Thoresens Vei 17, 1153 Oslo
Phone
+4722280311
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 4 152 | 5 512 | 5 501 | 5 880 | 6 885 |
| Staff expenses | −2 061 | −2 343 | −2 292 | −2 715 | −2 687 |
| EBITDA | −85 | 467 | 298 | −153 | 458 |
| Depreciation & amort. | −123 | −183 | −321 | −175 | −186 |
| EBIT | −208 | 284 | −23 | −327 | 272 |
| Net financials | −20 | −63 | −41 | −38 | −27 |
| Profit before tax | −229 | 221 | −63 | −366 | 245 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | −229 | 221 | −63 | −366 | 245 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 1 994 | 1 741 | 1 748 | 1 944 | 1 922 |
| Equity | 80 | 301 | 237 | −129 | 116 |
| Long-term debt | 997 | 895 | 617 | 417 | 217 |
| Short-term debt | 917 | 545 | 894 | 1 656 | 1 590 |
| Total debt | 1 914 | 1 441 | 1 511 | 2 072 | 1 806 |
EBITDA margin
6.7%
This company
15.8%
Market median
-58% vs market
20202024
Equity ratio
6.0%
This company
38.2%
Market median
-84% vs market
20202024
Return on equity
210.9%
This company
18.4%
Market median
+1046% vs market
20202024
Net profit margin
3.6%
This company
8.1%
Market median
-56% vs market
20202024
Asset turnover
3.58×
This company
1.12×
Market median
+220% vs market
20202024
Debt / equity
15.58×
This company
0.62×
Market median
-2413% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Board of Directors | 2025 | |
| Former (2) | ||
| Board of Directors | 2022 – 2023 | |
| Board of Directors | 2021 – 2022 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 20% | 20% | 2022 | |
| Individual | 16.67% | 16.67% | 2024 | |
| Individual | 16.67% | 16.67% | 2024 | |
| Individual | 16.67% | 16.67% | 2024 | |
| Individual | 16.67% | 16.67% | 2024 | |
| Individual | 16.67% | 16.67% | 2024 | |
| Individual | 8.33% | 8.33% | 2024 | |
| Individual | 8.33% | 8.33% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of SYMRA LEGESENTER AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Raja Khuram Iqbal | Board of Directors | 0 companies |
| Miert Skjoldborg Lindboe | Board of Directors | 0 companies |
| Camilla Udjus | Board of Directors | 0 companies |